328 related articles for article (PubMed ID: 28865738)
1. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris.
Moore G; Schelenz S; Borman AM; Johnson EM; Brown CS
J Hosp Infect; 2017 Dec; 97(4):371-375. PubMed ID: 28865738
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris.
Chesnay A; Bailly É; Desoubeaux G
J Mycol Med; 2021 Dec; 31(4):101173. PubMed ID: 34271481
[TBL] [Abstract][Full Text] [Related]
3. The comparative efficacy of antiseptics against Candida auris biofilms.
Kean R; McKloud E; Townsend EM; Sherry L; Delaney C; Jones BL; Williams C; Ramage G
Int J Antimicrob Agents; 2018 Nov; 52(5):673-677. PubMed ID: 29775686
[TBL] [Abstract][Full Text] [Related]
4. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris.
Abdolrasouli A; Armstrong-James D; Ryan L; Schelenz S
Mycoses; 2017 Nov; 60(11):758-763. PubMed ID: 28872735
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the susceptibility of Candida auris and Candida albicans to chemical disinfectants using European Standards EN 13624 and EN 16615.
Müller P; Tan CK; Ißleib U; Paßvogel L; Eilts B; Steinhauer K
J Hosp Infect; 2020 Aug; 105(4):648-656. PubMed ID: 32454076
[TBL] [Abstract][Full Text] [Related]
6. Different efficacies of common disinfection methods against candida auris and other candida species.
Fu L; Le T; Liu Z; Wang L; Guo H; Yang J; Chen Q; Hu J
J Infect Public Health; 2020 May; 13(5):730-736. PubMed ID: 32005617
[TBL] [Abstract][Full Text] [Related]
7. Surface disinfection challenges for Candida auris: an in-vitro study.
Kean R; Sherry L; Townsend E; McKloud E; Short B; Akinbobola A; Mackay WG; Williams C; Jones BL; Ramage G
J Hosp Infect; 2018 Apr; 98(4):433-436. PubMed ID: 29203448
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of octenidine- and chlorhexidine-based wash-mitts against Candida albicans and Candida auris - a comparative study.
Gugsch F; Tan CK; Oh DY; Paßvogel L; Steinhauer K
J Hosp Infect; 2024 Jan; 143():91-96. PubMed ID: 37949371
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity of octenidine dihydrochloride and ultraviolet-C light against multidrug-resistant Candida auris.
Ponnachan P; Vinod V; Pullanhi U; Varma P; Singh S; Biswas R; Kumar A
J Hosp Infect; 2019 May; 102(1):120-124. PubMed ID: 30261239
[TBL] [Abstract][Full Text] [Related]
10.
Ku TSN; Walraven CJ; Lee SA
Front Microbiol; 2018; 9():726. PubMed ID: 29706945
[No Abstract] [Full Text] [Related]
11. [Efficacy of sodium hydroxide at 2.5 %, chlorhexidine gluconate at 0.5 % and calcium hydroxide against Candida albicans].
Ndiaye D; Diongue K; Bane K; Seck A; Niang SO; Lèye Benoist F; Ndiaye D; Touré B
J Mycol Med; 2016 Dec; 26(4):317-322. PubMed ID: 27198757
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of antiseptics and disinfectants versus clinical isolates of Candida species.
Silverman J; Vazquez JA; Sobel JD; Zervos MJ
Infect Control Hosp Epidemiol; 1999 Oct; 20(10):676-84. PubMed ID: 10530645
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities.
Rutala WA; Kanamori H; Gergen MF; Sickbert-Bennett EE; Weber DJ
Infect Control Hosp Epidemiol; 2019 Mar; 40(3):380-382. PubMed ID: 30767810
[TBL] [Abstract][Full Text] [Related]
14. Testing chemical germicides against Candida species using quantitative carrier and fingerpad methods.
Traoré O; Springthorpe VS; Sattar SA
J Hosp Infect; 2002 Jan; 50(1):66-75. PubMed ID: 11825054
[TBL] [Abstract][Full Text] [Related]
15. An investigation of the bactericidal effect of certain antiseptics and disinfectants on some hospital isolates of gram-negative bacteria.
Ekizoglu MT; Ozalp M; Sultan N; Gür D
Infect Control Hosp Epidemiol; 2003 Mar; 24(3):225-7. PubMed ID: 12683517
[TBL] [Abstract][Full Text] [Related]
16. In situ and in vitro evaluation of two antiseptics for blood bank based on chlorhexidine gluconate/isopropyl alcohol and povidone-iodine.
Sánchez-Guzmán MJ; Loyola-Cruz MÁ; López-Ornelas A; Cruz-Cruz C; Durán-Manuel EM; Bello-López JM
Transfus Apher Sci; 2024 Feb; 63(1):103854. PubMed ID: 38061923
[TBL] [Abstract][Full Text] [Related]
17. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate.
Koburger T; Hübner NO; Braun M; Siebert J; Kramer A
J Antimicrob Chemother; 2010 Aug; 65(8):1712-9. PubMed ID: 20551215
[TBL] [Abstract][Full Text] [Related]
18. Survival and susceptibility of Burkholderia cepacia complex in chlorhexidine gluconate and benzalkonium chloride.
Kim JM; Ahn Y; LiPuma JJ; Hussong D; Cerniglia CE
J Ind Microbiol Biotechnol; 2015 Jun; 42(6):905-13. PubMed ID: 25794566
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters.
Hanna H; Bahna P; Reitzel R; Dvorak T; Chaiban G; Hachem R; Raad I
Antimicrob Agents Chemother; 2006 Oct; 50(10):3283-8. PubMed ID: 17005806
[TBL] [Abstract][Full Text] [Related]
20. Proposed phase 2/ step 2 in-vitro test on basis of EN 14561 for standardised testing of the wound antiseptics PVP-iodine, chlorhexidine digluconate, polihexanide and octenidine dihydrochloride.
Schedler K; Assadian O; Brautferger U; Müller G; Koburger T; Classen S; Kramer A
BMC Infect Dis; 2017 Feb; 17(1):143. PubMed ID: 28193164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
